JPMorgan plans capped contingent buffered notes on Gilead Sciences

By Susanna Moon

Chicago, June 20 – JPMorgan Chase & Co. plans to price 0% capped contingent buffered return enhanced notes due Dec. 31, 2015 linked to Gilead Sciences Inc. shares, according to an FWP filing with the Securities and Exchange Commission.

The payout at maturity will be par plus 1.5 times any gain in Gilead Sciences stock, up to a maximum return of 28.5% to 31.5%. The exact cap will be set at pricing.

Investors will receive par if the shares fall by up to 20% and will be fully exposed to any losses if the shares fall below the 80% trigger level.

J.P. Morgan Securities LLC is the agent.

The notes will price on June 26 and settle on July 1.

The Cusip number is 48127DNE4.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.